| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 08/30/2011 | CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 08/30/2011 | CA2393352C Adamantane derivatives |
| 08/25/2011 | WO2011101321A1 3-aminocarbonyl-substituted benzoylcyclohexanediones and their use as herbicides |
| 08/25/2011 | WO2011031042A3 Pegylated triiodinated aryl compound, and x-ray contrast agent comprising same |
| 08/25/2011 | WO2010149688A3 Antitumoral compounds |
| 08/25/2011 | US20110207634 Preparing ether carboxylates |
| 08/25/2011 | US20110207605 3-Aminocarbonyl-substituted benzoylcyclohexanediones and their use as herbicides |
| 08/24/2011 | EP1331922B1 Photo-labile pro-fragrance conjugates |
| 08/24/2011 | CN102164903A Synthesis routes to 2(S),4(S),5(S),7(S)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides |
| 08/24/2011 | CN102164887A Halogenated analogues of anti-fibrotic agents |
| 08/23/2011 | US8003819 Proteasome inhibitors |
| 08/23/2011 | US8003699 Amide compound and use thereof for controlling plant diseases |
| 08/23/2011 | US8003697 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 08/23/2011 | CA2516018C Hepatitis c inhibitor peptide analogs |
| 08/23/2011 | CA2368218C Oat extracts: refining, compositions and methods of use |
| 08/18/2011 | WO2011098839A2 Di-aspirin derivatives |
| 08/18/2011 | WO2011097797A1 Polyphenol acrylic acid derivative, preparation and use in preparing medicine thereof |
| 08/18/2011 | US20110201817 Levodopa prodrugs, and compositions and uses thereof |
| 08/17/2011 | CN102153433A N-monosubstituted-alpha-carbonylamide compound and preparation method thereof |
| 08/17/2011 | CN102151515A Amino acid type fluorocarbon surfactant, synthesis method and application |
| 08/17/2011 | CN102151262A Compounds for the treatment of metabolic disorders |
| 08/17/2011 | CA2731315A1 Novel method for the synthesis of ivabradine and the addition salts thereof with a pharmaceutically acceptable acid |
| 08/16/2011 | US7999132 Anthranilic acid derivative or salt thereof |
| 08/11/2011 | WO2011095576A1 Compounds for the treatment and prevention of influenza |
| 08/11/2011 | WO2011018170A3 Pesticidal carboxamides |
| 08/11/2011 | US20110195842 2,4,6-Phenyl-Substituted Cyclic Ketoenols |
| 08/10/2011 | EP2257523B1 Preparation of hydroquinone amide compounds with antioxidant properties |
| 08/10/2011 | EP1471052B1 Geranyl compounds |
| 08/10/2011 | CN102149675A Reagents and methods for the Beta-keto amide synthesis of a synthetic precursor to immunological adjuvant E6020 |
| 08/10/2011 | CN102149674A Fluorinated ether compounds and methods of using the same |
| 08/10/2011 | CN102149673A Fatty acid acetylated salicylates and their uses |
| 08/10/2011 | CN101664699B Catalyzer used for preparing acidamide compound and application thereof |
| 08/10/2011 | CN101333173B N-[4-(butanal-4-group)-benzoyl]-L-glutamic acid dimethyl ester compound and method for preparing pemetrexed by using the compounds |
| 08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
| 08/09/2011 | CA2662766C Diaryl ether derivatives and uses thereof |
| 08/09/2011 | CA2512000C Selective estrogen receptor modulator |
| 08/09/2011 | CA2431083C Inflammatory cytokine release inhibitor |
| 08/04/2011 | US20110190509 Processes for the Preparation of Bendamustine |
| 08/03/2011 | EP2349982A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 08/03/2011 | EP2349981A1 Biocompatible polymers for medical devices |
| 08/03/2011 | EP2349978A1 Gemini surfactants |
| 08/03/2011 | CN1729160B Drugs for chronic pain |
| 08/03/2011 | CN102140064A Compounds for the treatment of metabolic disorders |
| 08/03/2011 | CN101450910B Branch-like rare-earth metal complexes |
| 08/02/2011 | US7989657 Anthranilic acid derivatives |
| 08/02/2011 | US7989498 Inhibitors of IMPDH enzyme |
| 08/02/2011 | US7989478 Cinnamoyl compound and use of the same |
| 07/28/2011 | WO2011090323A2 Novel preparation method of 2-(2-n-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl)-n,n-dimethylacetamide |
| 07/27/2011 | EP2347652A1 Esteramides, their preparation and their use |
| 07/27/2011 | EP2346812A1 Process for manufacturing n,n-dialkyl lactamide |
| 07/27/2011 | CN102134203A Beta-alkyloxy propionamide, solvent, detergent and liquid drug composition and preparation method of beta-alkyloxy propionamide |
| 07/27/2011 | CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use |
| 07/26/2011 | US7985744 Vitamin D derivatives |
| 07/21/2011 | WO2011087837A2 Fungicidal 2-(bicyclic aryloxy)carboxamides |
| 07/21/2011 | WO2011086565A1 Method for preparation of enantiomerically enriched and/or racemic gamma-amino acids |
| 07/21/2011 | WO2011085454A1 Gp120 -binding benzene compounds and saccharide compounds |
| 07/21/2011 | WO2011061330A3 Use of physiological cooling active ingredients, and agents containing such active ingredients |
| 07/21/2011 | WO2011037833A3 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents |
| 07/21/2011 | US20110178088 Tetrahydro-naphthalene derivatives |
| 07/20/2011 | EP2345635A1 Amino acid derivative |
| 07/20/2011 | EP2345633A1 Optically active vinyl-cyclopropane carboxylic acid derivative and optically active vinyl-cyclopropane amino acid derivative manufacturing method |
| 07/20/2011 | CN102127005A Intermediate of alvimopan and synthesis method thereof |
| 07/20/2011 | CN102126993A Resveratrol derivative and application thereof to preparation of antitumor medicaments |
| 07/19/2011 | US7981938 Colchicine compositions and methods |
| 07/19/2011 | US7981923 Tetralin and indane derivatives and uses thereof |
| 07/19/2011 | CA2420279C Selective androgen receptor modulators and methods of use thereof |
| 07/14/2011 | WO2011084098A1 Process for making a metabotropic glutamate receptor positive allosteric modulator - 874 |
| 07/14/2011 | US20110172239 Compounds, Compositions and Methods for the Treatment of Amyloid Diseases and Synucleinopathies such as Alzheimer's Disease, Type 2 Diabetes and Parkinson's Disease |
| 07/14/2011 | CA2786327A1 Process for making a metabotropic glutamate receptor positive allosteric modulator - 874 |
| 07/13/2011 | EP2343273A1 Novel type i natural ceramide derivative and method for producing same |
| 07/13/2011 | EP2341891A2 Monoester of n-undecylenoyl phenylalanine and polyol, method for preparing same, and use of said esters as a skin lightening agent |
| 07/13/2011 | EP1259478B1 Covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids functionally active on the cb2 cannabinoid receptor |
| 07/12/2011 | US7977506 Amino acid for delivering active materials; bioavailability |
| 07/12/2011 | US7977387 Aminobenzophenone compounds |
| 07/07/2011 | US20110166117 Novel Compounds |
| 07/07/2011 | US20110165101 Photo-labile pro-fragrance conjugates |
| 07/06/2011 | CN102119142A Salicylamide derivatives as nicotinic alpha 7 modulators |
| 07/06/2011 | CN102119141A Novel polymorphic forms of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
| 07/06/2011 | CN102119140A Sphingosine-1-phosphate (S1P) receptor antagonists and methods for use thereof |
| 07/06/2011 | CN102119138A Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
| 07/06/2011 | CN101386581B Method for preparing acetsalicylamide |
| 06/30/2011 | WO2011078172A1 Process for production of optically active 3-substituted glutaric acid monoamide |
| 06/30/2011 | US20110160433 Benzylic compound |
| 06/29/2011 | EP2338886A2 Naphthalene derivatives |
| 06/29/2011 | EP2039354B1 Compounds blocking the nmda receptor channel and pharmaceutical agent using the same |
| 06/29/2011 | EP1678143B1 N-substituted pyrazolyl carboxanilides |
| 06/29/2011 | CN101186584B Process for preparing carboxamides by hydrolysis of carboxylic acid nitriles in the presence of a catalyst comprising manganese dioxide |
| 06/28/2011 | US7968721 Coupling a N-phenyl-1-bromo-2-substituted propamide with a substituted hydroxy-, amino-, phosphino-, or seleno- benzene compound; crystallization and filtration; industrial scale, high purity; non-steroidal agonists |
| 06/28/2011 | US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/28/2011 | US7968601 Treating excess cortisol formation; obesity, cardiovascular disorders, glaucoma, osteoporosis, Alzheimer's Disease; antidiabetic agents |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/28/2011 | CA2522748C Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide |
| 06/23/2011 | WO2011074643A1 Prophylactic or ameliorating agent fo pigmentation |
| 06/23/2011 | US20110152291 Novel aromatic compounds and their use in medical applications |
| 06/23/2011 | US20110152226 Development of New Selective Estrogen Receptor Modulators |
| 06/23/2011 | CA2784308A1 Preventing or ameliorating agent for pigmentation |
| 06/22/2011 | EP2334378A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 06/21/2011 | US7964648 Methods for concomitant administration of colchicine and a second active agent |
| 06/21/2011 | US7964647 Colchicine compositions and methods |
| 06/21/2011 | CA2577144C Alkynyl compounds as non-nucleoside reverse transcriptase inhibitors |